November 16, 2016 Comments Off on Trump in 30 seconds: Science and medicine in flux Posted in: General Biotechnology The latest on what the Trump presidency means for health care, hospitals, drug companies, and medical research. Tuesday, Nov. 15 The big news right now Even if Trump ends up being a friend to pharma, the private sector – and particularly pharmacy benefit managers – are set to put increasing pressure on drug prices. (Bloomberg) […]
The pharmaceutical industry is regularly chastised for failing to do enough to ensure that people in low and middle-income countries have access to its medicines. Yet the real picture is actually more nuanced, according to a newly released report that finds some – but not all – drug makers are making headway. Some companies, for […]